Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J ten Haaft

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Infectious Diseases|June 26, 2001
Protection from secondary human immunodeficiency virus type 1 infection in chimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cellsS S Balla-Jhagjhoorsingh, P Mooij, P J ten Haaft, et al.
Journal of Virology|February 7, 2001
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacyP Mooij, W M Bogers, H Oostermeijer, et al.
AIDS (London, England)|April 16, 1998
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infectionP Mooij, M van der Kolk, W M Bogers, et al.
The Journal of General Virology|January 8, 1999
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzeesW M Bogers, W H Koornstra, R H Dubbes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Infectious Diseases|June 26, 2001
Protection from secondary human immunodeficiency virus type 1 infection in chimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cellsS S Balla-Jhagjhoorsingh, P Mooij, P J ten Haaft, et al.
Journal of Virology|February 7, 2001
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacyP Mooij, W M Bogers, H Oostermeijer, et al.
AIDS (London, England)|April 16, 1998
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infectionP Mooij, M van der Kolk, W M Bogers, et al.
The Journal of General Virology|January 8, 1999
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzeesW M Bogers, W H Koornstra, R H Dubbes, et al.
Pageof 1